Answers are grounded in this paper and cite their sources.
Myasthenia gravis (MG) is an autoimmune disease that affects the neuromuscular junction and is characterized by muscle weakness. We present two clinical cases of patients with MG. The first case of the patient presents an uncharacteristic clinical picture in the form of dyspnoea with stridor. The second clinical case presents a severe form of MG, resistant to pharmacological cholinergic and immunosuppressive treatment, which resulted in a satisfactory improvement after eight plasmapheresis treatments and the conversion of pyridostigmine to the ambenonium.
No takes yet. Share an insight, caveat, or question.
Poleszak et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: